Get the Stockscreener App
2.09
19.31%
-0.50
Jaguar Health Inc stock is traded at $2.09, with a volume of 254.54K.
It is down -19.31% in the last 24 hours and down -12.55% over the past month.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
See More
Previous Close:
$2.59
Open:
$2.31
24h Volume:
254.54K
Relative Volume:
2.59
Market Cap:
$4.00M
Revenue:
$10.48M
Net Income/Loss:
$-37.74M
P/E Ratio:
-0.1291
EPS:
-16.1846
Net Cash Flow:
$-29.03M
1W Performance:
-0.48%
1M Performance:
-12.55%
6M Performance:
-90.71%
1Y Performance:
-92.19%
1-Day Range:
$2.06
$2.31
1-Week Range:
$2.02
$2.65
52-Week Range:
$1.9301
$35.25
Jaguar Health Inc Stock (JAGX) Company Profile
Name
Jaguar Health Inc
Sector
Industry
Phone
415-371-8300
Address
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Compare JAGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
JAGX
Jaguar Health Inc
|
2.09 | 4.50M | 10.48M | -37.74M | -29.03M | -16.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.81 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
568.36 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.41 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
650.56 | 39.02B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.60 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-11-17 | Initiated | Rodman & Renshaw | Buy |
Jaguar Health Inc Stock (JAGX) Latest News
Jaguar Health enters sixth ATM amendment with Ladenburg and Lucid - MarketScreener
Jaguar Health Extends Market Offering Agreement - TipRanks
Jaguar Health extends Lucid Capital Markets role in ATM agreement to year-end - Investing.com
Jaguar Health (JAGX) extends ATM manager role to Dec 31, 2025 | JAGX SEC FilingForm 8-K - Stock Titan
Earnings call transcript: Jaguar Health Q2 2025 sees revenue boost, stock tumbles - Investing.com
Transcript : Jaguar Health, Inc., Q2 2025 Earnings Call, Aug 14, 2025 - MarketScreener
Jaguar Health (JAGX) extends ATM manager to Dec 31, 2025, $22.9M raised | JAGX SEC FilingForm 424B5 - Stock Titan
Jaguar Health: Navigating Financial Turbulence Amid Orphan Drug Hopes - AInvest
Jaguar Health Reports Second Quarter 2025 Financials: Net Q2 2025 Revenue Up Approximately 35% Versus Net Q1 2025 Revenue | JAGX Stock News - GuruFocus
Jaguar Health Reports Second Quarter 2025 Financials: Net Q2 2025 Revenue Up Approximately 35% Versus Net Q1 2025 Revenue - ACCESS Newswire
Jaguar Health Earnings Preview: What to Expect - AInvest
Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates - Lohud
Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8: - GuruFocus
Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates | JAGX Stock News - GuruFocus
Jaguar Health Announces Double Header: Q2 Earnings Call and Emerging Growth Conference Presentation This Week - Stock Titan
Why Jaguar Health Inc. stock attracts strong analyst attentionPositive Outlook Long-Term Picks - sisaissue.com
Jaguar Health to Pursue Approval of Canalevia in European Union for Treatment of General Diarrhea in Dogs - Reno Gazette Journal
Form 424B3Prospectus [Rule 424(b)(3)] - ADVFN Brasil
Jaguar Health JAGX 2025Q2 Earnings Preview Downside Ahead on Recent Economic Developments - AInvest
Can Jaguar Health Inc. sustain its profitabilityLow Float Big Mover Alerts - thegnnews.com
Jaguar Health prices 0.25M shares at $6.09 in registered direct offering - MSN
Jaguar Health Inc expected to post a loss of $7.13 a shareEarnings Preview - TradingView
Jaguar Health Inc. Recovery Hinges on Volume BreakoutMarket Momentum Signal Generator Shows Trends - beatles.ru
What catalysts could drive Jaguar Health Inc. stock higher in 2025Build wealth faster with expert stock picks - Jammu Links News
What institutional investors are buying Jaguar Health Inc. stockCapitalize on emerging market sectors - Jammu Links News
What are analysts’ price targets for Jaguar Health Inc. in the next 12 monthsBuild a portfolio that outperforms the market - Jammu Links News
How does Jaguar Health Inc. compare to its industry peersHigh-velocity gains - Jammu Links News
Is Jaguar Health Inc. stock overvalued or undervaluedFree Market Volatility Navigation Tips - Jammu Links News
What is Jaguar Health Inc. company’s growth strategyHigh-margin investment plays - Jammu Links News
What analysts say about Jaguar Health Inc. stockInvest confidently with professional market insights - Jammu Links News
Is Jaguar Health Inc. a good long term investmentInvest smarter with daily market updates - Jammu Links News
Why is Jaguar Health Inc. stock attracting strong analyst attentionUnlock powerful market insights for success - Jammu Links News
How volatile is Jaguar Health Inc. stock compared to the marketMaximize returns with strategic stock selection - Jammu Links News
How many analysts rate Jaguar Health Inc. as a “Buy”High-return market picks - Jammu Links News
why is JAGX "Revenue Below Expectations" - AInvest
When is Jaguar Health Inc. stock expected to show significant growthFree Stock Recommendation With Proven Results - Jammu Links News
Is Jaguar Health Inc. a growth stock or a value stockRetirement Planning Target Finder Backed By Experts - Jammu Links News
What makes Jaguar Health Inc. stock price move sharplySmart Money Tracking Signal Generator Activated - metal.it
Can JAGX sustain its Q4 2024 earnings momentum? - AInvest
How did JAGX's Q4 2024 earnings surprise investors? - AInvest
How did JAGX's revenue and expenses shift in Q4 2024? - AInvest
What risks could impact Jaguar Health Inc. stock performanceTriple Digit Return Stock Predictions Released - metal.it
What is the risk reward ratio of investing in Jaguar Health Inc. stockRapid market gains - Jammu Links News
Does Jaguar Health Inc. stock perform well during market downturnsUnlock powerful investment tools for free - Jammu Links News
Should I hold or sell Jaguar Health Inc. stock in 2025Accelerate your capital gains today - Jammu Links News
What are the technical indicators suggesting about Jaguar Health Inc.High-margin investment plays - Jammu Links News
Has Jaguar Health Inc. Stock Ever Crashed Historical Volatility ReviewCapital Efficient Investment Tips - beatles.ru
What are Jaguar Health Inc. company’s key revenue driversStrongest growth potential - Jammu Links News
Jaguar Health Inc Stock (JAGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.26%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):